Jan 13, 2022 Ten key medtech themes for 2022 By Vinita Kailasanath Nida Rais The COVID-19 pandemic has accelerated the transformation of business models in the life sciences industry, with digital initiatives...
Mar 29, 2021 M&A in 2021 gets off to a flying start By Matthew Herman Robert Ashworth Richard Perks The M&A bull run that began in Q3 2020 shows no signs of slowing, with deal activity through the first three months of 2021 breaking the...
Dec 16, 2020 Global M&A in 2020 – and what to expect in 2021 By Matthew Herman Robert Ashworth Richard Perks With the festive season approaching, we thought this a good opportunity to look back at what happened in the world of M&A in 2020 – and...
Nov 16, 2020 The newly proposed UK national security and investment regime and its potential impact on inbound M&A from the US By Michele Davis Aimen Mir Paul Tiger Christine Laciak Thomas Lair +2 more... Show less On November 11, 2020, the UK government published the National Security and Investment Bill (the “NSI Bill”), which, when enacted into...
May 21, 2020 Impact of COVID-19 on the R&W insurance market By Paul Tiger Paul Humphreys Tomas Rua The impact of COVID-19 on M&A activity in global markets has predictably had knock-on effects on global R&W insurance markets with deal...
Apr 24, 2020 Part 2: Do I have to go through with this? A summary of recently filed MAE/MAC cases By Nathan Hembree Timothy Harkness Kate Apostolova As previously predicted in our blog piece Do I have to go through with this? A summary of recently filed MAE/MAC cases, material adverse...
Apr 19, 2020 Do I have to go through with this? A summary of recently filed MAE/MAC cases By Timothy Harkness Kate Apostolova Nathan Hembree We thought it might be helpful if we summarize the recent cases filed in the Delaware courts that implicate material adverse...
Apr 13, 2020 Why parties now need to focus on interim operating covenants By Ethan Klingsberg Paul Tiger Kelsey MacElroy Against the backdrop of unexpected developments arising from the COVID-19 pandemic, parties with signed, but not yet closed, M&A...
Apr 09, 2020 Waste not, want not: Delaware sounds a warning to directors and officers contemplating distressed acquisitions By Ethan Klingsberg Paul Tiger Chase Lax A warning to potential acquirors of distressed targets appears at the end of the Delaware Court of Chancery’s recent opinion in In re...
Apr 06, 2020 Navigating strategic alternatives in distressed scenarios: important takeaways for boards By Paul Tiger Kelsey MacElroy As the economy continues to experience daily turmoil in the wake of the COVID-19 crisis, it becomes increasingly likely that some...
Apr 02, 2020 A primer on private investments in public equity (PIPEs) in the US By Paul Tiger Andrea Basham Vinita Sithapathy In the current environment, as companies fear scarcity of capital and rush to draw on their existing credit lines, they should consider...
Mar 24, 2020 Coronavirus, force majeure and foreseeability: was the current pandemic foreseeable, and what would this mean for contract claims? By Timothy Harkness David Livshiz Christian Vandergeest For the vast majority of us, the speed and scope of the coronavirus pandemic came as a surprise. Only weeks ago, everything seemed...